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Conclusion
In this study the screening prevalence of HIV-associated neurocognitive disorder is higher than the earlier reports in Ethiopia and Africa. This indicates that early screening strategies and policies for cognitive health in people living with HIV/AIDS should be given a top priority.
Background
One of the most devastating health problems facing the human race in the 21 century is the Acquired Immunodeficiency Syndrome (AIDS) caused by the Human Immunodeficiency Virus (HIV) [1] . Sub-Saharan African (SSA) countries are highly affected by this disease, accounting 80% of the cases, despite the continent constituting only 11-12% of the world's population [1, 2] . HIV is a neurotropic virus that affects the sub-cortical structure of the brain [3] . Cognitive impairment of patients due to HIV is called HIV-associated neurocognitive disorder (HAND) [4, 5] . It results in a defect in speed of problem solving ability, loss of memory and attention [6] . HAND is a collective term which comprises 3 levels of illness that ranges from asymptomatic neurocognitive impairment to minor neurocognitive disorder and frank dementia [1, [7] [8] [9] [10] . Even though severe form of HAND like dementia is decreasing after the introduction of combined highly active antiretroviral therapy (cART), mild and asymptomatic form of neurocognitive disorder is still prevalent and a major problem globally [4, [10] [11] [12] [13] [14] [15] [16] [17] . Despite cART reduces the prevalence of HAND, accessing anti-retroviral therapy (ART) in sub Saharan countries is a big problem so far. Moreover the late presentation of patients in the follow-up clinic makes them vulnerable to HAND and other HIV related complications [18] [19] [20] .
The prevalence of HIV associated neurocognitive disorder (HAND) in adult people living with HIV/AIDS (PLWHA) ranges from 19% to 52% in developed [19, 20] , and 14% to 64% in developing countries [9, 10] .
HAND predisposes HIV infected patients for poor adherence, unsafe sex, substance abuse, alcohol addiction, lost to follow up and worsens their quality of life. All these factors can accelerate HIV symptoms, their progression towards AIDS defining opportunistic infections and death [7, 9, 21] .
Studies carried out in Singapore, Nigeria, Cameroon, Botswana, Malawi and Dessie Ethiopia indicated that being female, old age and low educational status were an independent risk factor for HIV associated neurocognitive disorder [2, 6, 9 , 10, 18, 21-23], whereas, studies carried out in Brazil, Singapore and Northern Nigeria indicated that CD4 count less than 500 cells/mm3 was associated with HIV-associated neurocognitive disorder [2, 6, 18, 24] . Moreover, a study done in South Africa in 2013 showed that highly active anti-retroviral treatment (HAART) naïve and late clinical stage of the illness was factors affecting HIV-associated neurocognitive disorder [20, 23] . Body mass index, depression and alcohol abuse were also found to be associated with HIV-associated neurocognitive disorder in Uganda [1] . In addition to the above factors, the presence of opportunistic infections and poor medication adherence were associated with HIV-associated neurocognitive disorder [8, 25] .
In Ethiopia, particularly in the study area, there is deficient information regarding the prevalence of HIV-associated neurocognitive disorder and its associated factors among peoples living with HIV/AIDS though there are many people living with HIV/AIDS [8] .
Therefore, this study will help to determine the prevalence and the most important associated factors which have an impact on HIV-associated neurocognitive disorders among peoples living with HIV/AIDS.
Methods

Study design, setting and area
An institution based cross-sectional study was conducted from April to May 2017 in the Gamo Gofa zone, which is located at a distance of 505 km from Addis Ababa (the capital of Ethiopia). It is administratively organized in 15 Woreda, 2 administrative towns, 34 urban and 452 rural kebeles. The total populations are 2,040,972 according to the 2017 Zonal report. There are 3 public hospitals, 73 health centers and 471 health posts in the Gamo Gofa zone currently functional according to unpublished zonal health officials' report 2017.
Study population
The target population was PLWHA aged between 18 and 64 years who had treatment follow up at Gamo Gofa zone public Hospital ART clinics. Those selected PLWHA who was getting ART service during the data collection period were included in the study. PLWHA who were seriously ill during the study period, known psychiatric and neurological problems (depression, psychosis and epilepsy/seizure disorders) were excluded from the study.
Sample size and sampling procedures
Sample size was determined by taking the two significant variables from previous studies which was CD4 count less than 500 cells/mm 3 and having a primary educational level or less in a study done at South Wollo, Ethiopia [8, 22] with 80% power, 0.36 odds ratio, 95% CI and a none response rate of 10%. Based on this assumption, the final sample size was 697. Systematic random sampling was employed to select study participants. From 3 Hospitals, samples were allocated to each Hospital proportionally based on their number of PLWHA. Finally, PLWHA in every 3 rd PLWHA from their regular follow up in the hospital was enrolled in the study by systematic random sampling method.
Data collection tools and procedures
A structured questionnaire was used to collect data on socio-demographic characteristics of the participants and clinical factors of HIV/AIDS (WHO stages, CD4 count. . .etc.). The WHO staging system uses the laboratory method to categorize the immune status of HIV/AIDS patients by their total lymphocyte counts (CD4) and clinical markers believed to have prognostic significance resulting in four categories. WHO stage I, II, III & IV before the initiation of cART and WHO stage T1, T2, T3 & T4 six months after cART initiation. T stands for treatment. This staging system has proven reliable for predicting morbidity and mortality in HIV/ AIDS patients especially in developing countries where sophisticated laboratory investigations are inaccessible [26] . Other variables that were important for the objective were extracted from the patient's chart. International HIV Dementia Scale (IHDS) was used as a screening tool to identify individuals who are at risk of HAND. The presence of HAND was screened by an IHDS score of <9.5 in this study. This tool has been validated in Sub-Saharan African countries, particularly in South Africa, Cameroon, Botswana, Uganda and Ethiopia and found to have good psychometric properties in African populations with sensitivity of 88% and 80% and specificity of 50% and 55% at a cutoff 10 or less [1, 9, 10, 20] . HAND consists of the three subsets of tests, namely motor speed, psychomotor speed and memory-recall test. The procedure was as follows:
Motor Speed test. It was measured by instructing the participant to open and close the first two fingers of his/her non-dominant hand as widely and as quickly as possible over a 5-second period. The score was given as follows (4 = 15 in 5 seconds 3 = 11-14 in 5 seconds, 2 = 7-10 in 5 seconds, 1 = 3-6 in 5 seconds, 0 = 0-2 in 5 seconds).
Psychomotor speed test. In this procedure participant was ordered to perform the following activities by their non-dominant hand within 10 seconds as fast as possible. First clench their fist on a flat table secondly put the hand flat on the table with the palm down and finally make their flat hand perpendicular to the table on the fifth digit side. This procedure was demonstrated to the participant by the data collector and the participant was allowed to practice the procedure correctly before actual 10 second sequence was performed. The number of sequences correctly performed within 10 seconds up to a maximum number of 4 is scored (4 = 4 sequences in 10 seconds, 3 = 3 sequences in 10 seconds, 2 = 2 sequences in 10 seconds, 1 = 1 sequence in 10 seconds and 0 = unable to perform).
Memory-Recall. In this procedure participants were asked to repeat four words after reciting by the data collector. The words are repeated by the data collector until the participant can repeat all four words correctly. The participants were asked to recall the four words after the above two procedures. For words not recalled, the participants were reminded with a 'semantic' clue as follows: Animal (Cow), a piece of cloth (T-shirt), Vegetable (cabbage), and color (Blue). 1 point was given for each word spontaneously recalled and 0.5 points for each correct answer after semantic clues and the maximum point were scored out of 4. Finally IHDS score was calculated by adding all three subsets out of 12 points and participants who scored <9.5 were screened as having a risk of HAND in this study.
Adherence of patients to their medication was assessed using Morsiky-8 item scale (MMAS). The MMAS-8 is a self-report questionnaire with 8 questions (items). Items 1 through 7 have response choices "yes" or "no" whereas item 8 has a 5-point Likert response choices. Each ''no" response is rated as ''1" and each ''yes" is rated as ''0" except for item 5, in which each response ''yes" is rated as ''1" and each ''no" is rated as ''0". For item 8, if a patient chooses a response ''0", the score is ''1" and if they choose response ''4", the score is ''0". Responses ''1, 2, 3" are respectively rated as ''0.25, 0.75, 0.75". Total MMAS-8 scores can range from 0 to 8 and have been categorized into three levels of adherence: high adherence (score = 8), medium adherence (score of 6 to < 8), and low adherence (score< 6) [8, 27] .
Alcohol use disorder identification test. The Alcohol Use Disorder Identification Test (AUDIT) is a 10-item instrument designed by the World Health Organization to screen excessive consumption, hazardous, and harmful use of alcohol. The instrument has been validated in many countries, including Sub-Saharan African countries. A score of 8 and above is indicative of either harmful use or dependence [2] . And a cut of point > = 8 was used in this study.
Drug abuse screening test. Drug Abuse Screening Test (DAST) instrument is designed to screen for drug use other than alcohol [28] .The DAST-10 version was used in this study and is answered in a ''yes or no" pattern. A score of 3 and above is indicative of a problem with psychoactive substance abuse [2] .
Data quality management
Data collectors were trained for two days by doing standardization exercise in order to minimize errors. The questionnaire was developed in English and then translated into Amharic (local language) and back to English then review was made for its consistency. Data was collected after pretest has been conducted on 35 (5%) of PLWHA from non-selected health institutions. The principal investigator made day to day on-site supervision during the whole period of data collection. The collected data were reviewed and checked for completeness, accuracy and consistency by the investigator.
Data management and analysis
Data entry and cleaning was made using Epidata 3.1 and exported to SPSS software package version 20 for analysis.
Cross-checking and data cleaning was carried out by running frequencies of each variable. For specific objective one, descriptive statistical methods such as frequencies, percentages, proportion with 95% C.I has been used. Mean and standard deviation was also used to summarize various characteristics of the participants. For specific objective two, cross tabulation and bivariable logistic regression were used to explore the relation between the outcome variable and the different independent variables using crude odds ratio with 95% C.I. Finally, to determine the independent factors associated with the outcome variable, multivariable logistic regression model were done, and presented using adjusted odds ratio (AOR) with 95% confidence interval. Variables with P-value < 0.2 of the bivariable analysis were taken in to the multivariable logistic regression model. Model fitting was checked using log likelihood and Hosmer-Lemeshow test. Finally, variables with P < 0.05 in the multivariable analysis were considered as significant.
Results
Socio-demographic characteristics
Six hundred eighty four (684) people living with HIV/AIDS were involved in this study, making the response rate of 98%. The mean age of the respondents was 38.8±8.8 years. Among the study participants majority 383 (56.0%) were females and 284 (41.5%) were widowed ( Table 1) .
Clinical status
Most of the participants 589 (86.1%) were in WHO clinical stage T1 category and their mean CD4 count was 610 ± 278 cells/mm 3 . And 95.6% of the participant had no any history of central nervous system related opportunistic infections. Adherence of participants with their ART medication was assessed using Morsiky-8 item scale (MMAS). And MMAS ranges from 0-8 points. The majority of the participants 408 (59.6%) were low adherent to their ART medication i.e. they scored <6 points by this scale (Table 2) .
Alcohol and other drug usage pattern
Alcohol use disorder identification test was used to screen excessive consumption, hazardous, and harmful use of alcohol. And in this study majority 624 (91.2%) of the participants never used alcohol excessively, hazardously or harmfully. Drug abused screening test (DAST-10) was also used to screen participants for their drug usage other than alcohol and most of the participants 628 (91.8%) scored between 0-3 which is non-drug abuse.
Prevalence of HIV associated neurocognitive disorder (HAND)
Among the study participants who have been screened for HAND, 459 (67.1%, 95% CI; (63.6, 70.5)) tested positive for HAND. Procedural implementation of international HIV dementia scale (IHDS) was as follows: The first measurement on IHDS was timed finger tapping, on this part motor speed was assessed, 65 (9.5%) were scored 4 out of 4 which is normal. On the second part psychomotor speed measurement was assessed, of whom 109 (15.9%) had performed the sequential procedure, scoring 4 out of 4. Finally, memory recall was assessed and 174 (25.4%) had recalled all the four items without any clue scoring 4 out of 4.
Factors associated with HAND
Bivariable and multivariable analysis showed that the association between HIV-associated neurocognitive disorder and marital status, body mass index, WHO clinical status and occupational status were significant. After controlling /adjusting other variables like (sex, alcohol abuse, religion, educational status, CD4 count, drug abuse, duration with ART, medication adherence, monthly income, comorbid illness, opportunistic infection history). The odds of HAND among married participant decrease by 62.3% compared to those with unmarried/single participants (AOR = 0.377 CI (0.213-0.666)).
In this study the likelihood of having the risk of HAND among peoples living with HIV/ AIDS (PLWHA) was four times in those participants who had a body mass index of less than 16 kg/m 2 than those participants who had a body mass index of 18.5-24.9 kg/m 2 (AOR 4.389 CI (1.603-12.016).The odds of having HAND among unemployed participants were three times higher than those who were employed (AOR = 3.181 CI (1.752-5.777)). Similarly, late 
Discussions
Determination of the prevalence and associated factors of HIV-associated neurocognitive disorders among peoples living with HIV/AIDS by institutional based cross sectional study in southern Ethiopia public hospitals was the main focus of this study. At the base of this, the prevalence of HAND among people living with HIV/AIDS was 67.1%. And IHDS demonstration was highly associated with marital status, body mass index, occupational status and WHO clinical stage category. The finding of this study was in line with the study done in Sub Saharan African population which showed the prevalence of HAND (64.4%) [1] , and in Kenya (65.6%) [29] .
However, the prevalence of HAND in the current study was higher than a cross-sectional study done in Brazil (53%) [ [32] . The differences may be accounted for the neurovirulence strain differences and hidden sociodemographic differences. In addition, most of the above studies used smaller sample size than this study. Above all the difference in the care of patients with HIV in different settings might be different and will contribute to the difference in prevalence.
On the other hand, the prevalence of HAND in this study was lower than a cross-sectional study conducted among 400 PLWHA in Bamenda, Cameroon (85%), at Bamenda Regional Hospital AIDS-treatment Centre [9] .
The discrepancy in the prevalence rate could be explained by the existence of different neurovirulent clades in different countries. Clade A and D are the most common clades/sub types in sub Saharan African countries. But in Ethiopia clade C is the prevalent sub type [33] . Even though Clade C is a neurotropic virus like A and D, it is the least common cause of neurocognitive disorder than A&D [34] . The differences in the predictors for the development of HAND might also have an effect for the discrepancy since in the previous study the common predictor was stated as having primary education or less and having HIV symptoms but not in the current study. And the discrepancy can also be explained by sample size differences; in previous study lesser sample size (400), much less than the current study was used. In addition, other possible reasons for the differences between the present and other studies were mainly due to differences in the method used, differences in study populations, using different cutoff points in different studies, some inappreciable cultural and educational difference, and environmental factors. Furthermore, discrepancies may also be explained by the application of the IHDS which might need well-educated participant.
This study found out that, marital status was significantly associated with the development of HAND. Married participants were less likely to develop HAND than single individuals. This finding is also supported by a cross sectional study conducted among 225 participants in Tanzania which indicated that living alone than married is an independent risk factor for HAND [35] . The possible reason is that married couples can promote a healthy life like to motivate each other to exercise, eat healthfully, maintain social ties, smoke and drink less [36] [37] [38] [39] . Furthermore, married couples can prevent modifiable risk factors for HAND [40, 41] . All This evidence is also supported by Cache County Dementia Progression Study which found out that nutritional status was associated with faster decline in cognitive dysfunction [50] . A longitudinal study done among 125 HIV/AIDS infected participants at The Miriam Hospital/ Brown University, USA stated that malnutrition is a risk factor for neurocognitive disorder [51] .
In the current study occupational status had significant association with HAND. Unemployment was an independent risk factor for the development of HAND. This study is supported by a cross sectional study done among 361 participants in Asia [52] , a cohort study done in Thai [53] and cross sectional study among 604 participants in Ireland and Irish ART Clinic [54] . Employment makes a person to acquire new skills, participate in different organization and engage socially, all of these can give meaning to a person's life and provide income [55] . In addition, these activities can boost a person's cognitive health. Unfortunately, if they get unemployed, they will lose or limit at least employment driven cognitive health benefits [56, 57] . For people with HIV/AIDS money is used to buy different prophylactic drugs, vitamins, antiretroviral drugs and most importantly for food. In general, low socioeconomic status was independently associated with neurocognitive disorders in patients with HIV/AIDS [56, 58] . In the present study, there was statistically significant association between WHO clinical staging/late stage of the disease and HAND. This finding is supported by an observational cohort study done among 268 patients in the USA, demonstrate that this factor, was the predictive variables in the development of HAND [59] . An institution based cross sectional study conducted among 234 participants Ayder Comprehensive Specialized Hospital in Ethiopia, found out that late stage of the disease is an independent risk factor for neurocognitive disorder [32] . During late stage of the disease, there will be intense viremia both in the blood and Cerebro-spinal fluid (CSF). This can predispose patients for different central nervous system (CNS) related opportunistic infection. In addition the virus itself can replicate and multiply in different parts of the brain. Both mechanisms play a synergistic effect for the development of HIV associated neurocognitive disorders [60] .
In our study adherence status of participants to their ART medication is low, even though we didn't measure the serum concentration level of the drugs. But it wasn't statically significant for HAND in this study. However, low adherence to ART medication is an independent risk factor for HAND in cross sectional studies done among 595 participants in South Wollo Ethiopia [8] and among 418 participants in Northern Nigeria [12] . This variable is also an independent risk factor for HAND in different studies conducted previously [11, 17, 61, 62] .
But the association of HAND and adherence level has a reciprocal relationship in one systemic review [63] . A longitudinal study done among 225 participants in Boston, USA showed that adherence is highly affected by HAND [64] . Other similar studies also showed that HAND is a risk factor for low medication adherence [65] [66] [67] .
Even though drug abuse wasn't statically significant in this study, from 56 abuser participants 27 participants develop HAND. But this variable was an independent risk factor for HAND in a cross sectional study done among 423 participants in Deberemarkos Ethiopia [25] . It was also an independent risk factor for development of HAND in different Studies [68] [69] [70] .
One of the limitations of this paper is that antiretroviral treatment regimen wasn't recorded. It would have been better if we included this variable. Because, not all the drugs used to treat HIV penetrate the blood brain barrier (BBB) equally [7] . Regimens which contain drugs with better blood brain barrier crossing ability can suppress CNS HIV replication and prevents neurocognitive dysfunction [15, 71] . But in Ethiopia TDF-3TC-EFV are the most commonly used regimens.
Generally; the results of this study provide additional information on HAND particularly in the local areas where this study is done. The result of this study can also give some information on specific variables which affect HAND. Above all, the finding of this study will contribute about the burden and risk factor of HAND to the scientific world particularly in study areas.
Limitation of the study
Despite including participants from three hospitals it might not be applicable for all PLWHA in Ethiopia. This study included only patients on highly active antiretroviral therapy so being on HARRT might underestimate the prevalence of neurocognitive disorder. Since HARRT reduces the prevalence of HAND [72] [73] [74] [75] .
Conclusion
There is a high screening prevalence of HIV-associated neurocognitive disorder than those earlier reports in Ethiopia and Africa. The associated factors also vary from that of earlier studies. Therefore, this study indicates the need for formulating preventive cognitive health programs and policies for patients with HIV/AIDS.
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